OUR STRATEGY

Working to deliver the right treatment, to the right patient, at the right time.

Our Strategy

We are relentless in our ambition to develop tomorrow’s medicine by investing in and guiding, supporting, and developing biosciences companies around cutting-edge technologies.

Our investments focus on advancing personalized medicine. We collaborate with the brightest entrepreneurs and provide flexible and long-term support to ensure they reach their full potential to develop tomorrow’s therapies and transform patient outcomes.

We have recently re-branded as ‘ATON’ to reflect our company’s new vision and strategy, signalling a new direction for the organization.

As ATON embarks on this transformative journey, it remains rooted in its mission to advance therapies for the good of patients, medicine, and society. The re-branding of ATON marks a pivotal moment for the company as it sets its sights on reshaping the landscape of bioscience and ushering in a new era of personalized medicine.

INVESTORS

Accelerating the pursuit of tomorrow’s therapies

Turn perspectives into reality. Turn present into future. Turn risk into opportunity. Turn investment into journey. Turn research into medicine. Turn to Aton.

Investor Center

Products and Platforms

We invest in leading-edge companies and technology platforms that have proven results. Our aim is to identify, acquire and develop unique, disruptive, and powerful products or services that can help us advance therapies for the good of patients, medicine, and society.

State of development & sector

We seek companies built on strong scientific foundations, with a concrete impact within the biomedical area. We want to diversify risks by investing in companies in different stages.

Taking an active role

We are supportive and hands-on investors. We pilot the strategy and provide operational functions such as accounting, human resources, marketing, etc.

Anticipating the next wave of medical breakthroughs

We have a strong knowledge of the pharmaceutical industry, allowing us to possess firsthand market insights. This enables us to foresee emerging therapeutic trends and identify growing areas of interest spanning a wide range of indications.

OUR PLATFORMS

Game-changing life science platforms

Our platforms are driving a fundamental shift to provide opportunities for more personalization and precision products and services. Diverse platforms, each with unique world-leading technologies and a team of experts united by one desire, to advance and accelerate medical discoveries for the good of patients, medicine, and society. Aton’s platforms bring significant expertise to guide and support life science businesses in achieving their goals with greater efficiency.

Preclinical & Clinical Services

We accelerate and secure the entire drug development process with a patient-centred approach, optimizing our customers' time and resources so...

Learn more

Monoclonal Antibodies Production

Bcell Design is a leading provider of leading-edge monoclonal antibodies with human Fc for companies specializing in in vitro diagnostic...

Learn more

Medical Device Production

Stemcis has designed and manufactured all-in-one, sterile, and single-use surgical kits to revolutionize the field of fat transfer surgery.

Learn more

Laboratory Equipment Production

Its accuracy and sensitivity surpass traditional methods, facilitating real-time analysis and personalized medicine. Unravel the complexities of molecular behaviors and...

Learn more

Human Tissue Provision

We ensure that all clinical tissues are procured through rigorous ethical guidelines, with informed consent obtained from donors.

Learn more

Let’s talk!

Please leave your details and we’ll get back to you.

Get in touch